|By Adams, Ashley R|
Breast cancer is a costly disease, averaging
Wang et al.3 performed a study of the population specific to
Screening for breast cancer detects premalignant and early lesions and favorably impacts mortality. The prognosis of breast cancer is directly related to stage at presentation. We sought to determine the relationship between presenting stage and insurance status.
There were 3375 patients in the registry with early- stage breast cancer. The study population was 84.41 per cent white, 14.28 per cent black, and 1.01 per cent other races (0.30% of patients had no recorded race; Table 1). Of the study population, 27.88 per cent were with
Stage 0 breast cancer was diagnosed in 12.74 per cent of
Stage 2 breast cancer was diagnosed in 40.13 per cent of
At our institution, which serves a city of over 100,000 and has a catchment area of over 500,000 people, payer status was found to influence the stage of breast cancer at presentation. The majority of the patients in our study population were white. The largest insurance designation overall was that of private in- surance. Of those with government insurance or no in- surance, the largest designation was
Stage II breast cancer was more likely to be di- agnosed in
In conclusion, patients with
1. Henry RE. Highlights from ASCO 2010: An update on breast cancer for payers and pharmacists.
2. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999;91:1409-15.
3. Wang F, McLafferty S, Escamilla V, et al. Late-stage breast cancer diagnosis and health care access in
4. Halpern MT, Bian J, Ward EM, et al. Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer 2007;110:403-11.
Presented at the
Address correspondence and reprint requests to
|Copyright:||(c) 2014 Southeastern Surgical Congress|